| Financial Year |
March 31 2023 |
| Monetary Funds |
670,180,495.72 |
| Held-for-trading Financial Assets |
60,953,418.32 |
| Notes Receivable |
26,568,300.13 |
| Accounts Receivable |
943,573,856.43 |
| Advances to Suppliers |
3,055,600.20 |
| Other Receivables |
27,757,742.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
587,625,525.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,472,868.24 |
| Total Current Assets |
2,413,818,880.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
83,901,669.68 |
| Fixed Assetes |
364,191,734.24 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,931,454.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,165,582.35 |
| Deferred Income Tax Assets |
11,349,607.31 |
| Other Non-Current Assets |
67,635,417.10 |
| Sub-Total of Non-Current Assets |
660,474,538.05 |
| Total Assets |
3,074,293,418.08 |
| Short-Term Loans |
264,365,398.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
218,148,630.57 |
| Accounts Payable |
881,604,636.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,563,078.77 |
| Taxes Payable |
7,118,387.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,118,663.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,508,615.59 |
| Other Current Liabilities |
86,785.30 |
| Sub-Total of Current Liabilities |
1,488,058,703.38 |
| Long-term Loans |
60,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
159,883,646.56 |
| Total Liabilities |
1,647,942,349.94 |
| Paid-In Capital(Or Share Stock) |
194,525,970.00 |
| Capital Surplus |
668,910,559.29 |
| Surplus Reserve |
55,509,163.43 |
| LESS:Treasury Stock |
21,598,944.00 |
| Undistributed Profits |
532,812,620.56 |
| Minority Stockholder's Interest |
-5,201,283.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,431,552,351.68 |
| Owner's Equity（Stockholder's Equity） |
1,426,351,068.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,074,293,418.08 |
